Abstract
Macroautophagy (hereafter referred as to autophagy) is a vacuolar lysosomal degradative pathway for cytoplasmic macromolecules and organelles. There is growing evidence that autophagy is controlled by tumor-regulating molecules, and that it is downregulated during the early stages of tumorigenesis. Nevertheless, the relationship between autophagy and tumor progression seems to be complex, since in response to various stress situations, cancer cells are able to trigger autophagy either as a survival mechanism or conversely as a mechanism leading to cell death. Therefore, depending on the context, autophagy may trigger opposite outcomes in cancer cell fate. These two aspects of autophagy should be further taken into account in view of its possible modulation for cancer treatment.
Keywords: Autophagy, tumor, cancer therapy, apoptosis, cell death, cell survival
Current Cancer Therapy Reviews
Title: Macroautophagy as a Target of Cancer Therapy
Volume: 3 Issue: 3
Author(s): Severine Lorin, Patrice Codogno and Mojgan Djavaheri-Mergny
Affiliation:
Keywords: Autophagy, tumor, cancer therapy, apoptosis, cell death, cell survival
Abstract: Macroautophagy (hereafter referred as to autophagy) is a vacuolar lysosomal degradative pathway for cytoplasmic macromolecules and organelles. There is growing evidence that autophagy is controlled by tumor-regulating molecules, and that it is downregulated during the early stages of tumorigenesis. Nevertheless, the relationship between autophagy and tumor progression seems to be complex, since in response to various stress situations, cancer cells are able to trigger autophagy either as a survival mechanism or conversely as a mechanism leading to cell death. Therefore, depending on the context, autophagy may trigger opposite outcomes in cancer cell fate. These two aspects of autophagy should be further taken into account in view of its possible modulation for cancer treatment.
Export Options
About this article
Cite this article as:
Severine Lorin , Patrice Codogno and Mojgan Djavaheri-Mergny , Macroautophagy as a Target of Cancer Therapy, Current Cancer Therapy Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339407781368369
DOI https://dx.doi.org/10.2174/157339407781368369 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET
Current Drug Targets Identification of Flavonoids by LC-MS/MS in Leaves Extract From <i>Protium heptaphyllum</i> (Aubl.) March and Antioxidant Activity in Mice
The Natural Products Journal Medullary Thyroid Cancer: New Targeted Molecular Therapies
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Effects of Colchicum baytopiorum on Regulatory Genes of Apoptotic and Autophagic Cell Death in HeLa Cells
Current Pharmaceutical Biotechnology Recent Advances in Gene Therapy of Endometriosis
Recent Patents on DNA & Gene Sequences New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry Monotherapy for the Treatment of Lymphedema in Children: A Review
Current Pediatric Reviews 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience
Current Radiopharmaceuticals Using Cytokines to Treat Cervical Intraepithelial and Invasive Neoplasia
Recent Patents on Anti-Cancer Drug Discovery Methods of Screening-Purification and Antimicrobial Potentialities of Bacteriocin in Health Care
Current Drug Metabolism System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening
Current Medicinal Chemistry Lipid-Protamine-DNA-Mediated Antigen Delivery
Current Drug Delivery Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research An Effective Vaccination Approach Augments Anti-HIV Systemic and Vaginal Immunity in Mice with Decreased HIV-1 Susceptible α4β7high CD4+ T Cells
Current HIV Research Creating A Standard of Care for Fertility Preservation
Current Women`s Health Reviews Cystic Hygroma with Multiple Benign Bone Lymphangiomas in an Adult Patient: A Rare Entity in the Differential Diagnosis of Multiple Osseous Lesions in Oncology Practice
Current Medical Imaging Serine Proteinase Inhibitors in the Skin: Role in Homeostasis and Disease
Current Protein & Peptide Science Impact of PLK-1 Silencing on Endothelial Cells and Cancer Cells of Diverse Histological Origin
Current Gene Therapy Applications of Solid-State Fermentation Process in Biological Detoxification of Industrial Wastes
Current Biochemical Engineering (Discontinued) A Potent Anti-Carcinoma and Anti-Acute Myeloblastic Leukemia Agent, AG490
Anti-Cancer Agents in Medicinal Chemistry